FEB 17, 2018 12:35 PM PST

Heroin Vaccine Treats Addiction and Lethal Overdose

WRITTEN BY: Kara Marker

After five years of optimizing, researchers from the Scripps Research Institute (TSRI) have come up with the best candidate for a heroin vaccine. The new drug, composed of three key ingredients, could treat the addiction to heroin and prevent lethal overdose.

"We believe that a heroin vaccine would be tremendously beneficial for people who have a heroin substance use disorder but have found difficulty in trying to quit,” explained first author Candy S. Hwang, PhD.

The vaccine is built by binding a heroin molecule to a protein recognized by the immune system. The heroin molecule does not trigger an immune reaction on its own. When the vaccine initiates an immune response, antibodies are produced that bind to heroin molecules that build up when a person is using the drug. The antibody binding prevents the drug from reaching the brain and causing a high.

In theory, without the high, drug users won’t be tempted to use the drug. The heroin vaccine also prevents lethal overdose by preventing the drug from reaching the brain. Additionally, an adjuvant is added to the vaccine to make the immune response even stronger.

In the new study, researchers assessed the ability of 20 different protein/adjuvant combinations. They were looking for the pair best able to provide shelf stability, measured based on temperature and storage time.

"Our goal was to prepare a vaccine that could be advanced to clinical trials,” Hwang explained. “As such, we were looking for the best combination of [heroin], carrier protein and adjuvant to keep the vaccine both stable for transport and storage but still efficacious."

They found that the best candidate was a combination between the carrier protein tetanus toxoid (TT) and two adjuvants, alum and CpG ODN. And in fact, alum is one of only a handful of adjuvants already approved by the FDA to be included in vaccines.

By confirming that the drug’s ingredients are effective, safe, and stable, researchers are on the brink of bringing their new heroin vaccine to human clinical trials.

Researchers report that almost 16,000 deaths from heroin overdose occurred in the United States between 2000 and 2016, and that number is only expected to rise, faster and faster.

The present study was published in the journal Molecular Pharmaceutics.

Source: The Scripps Research Institute

 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 24, 2018
Cancer
APR 24, 2018
CAR-T Cell Therapy 101
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a useful tool for cancer treatments in a small number of cancers thus far. This area of treatment research is expanding rapidl...
APR 30, 2018
Clinical & Molecular DX
APR 30, 2018
Reducing Dependency on Antibiotics in Hospitals
How can small community and rural hospitals create antibiotic stewardship programs to reduce the danger of antibiotic resistance? Scientists from the Inter...
MAY 16, 2018
Clinical & Molecular DX
MAY 16, 2018
Malaria Changes the Way You Smell
Malaria is a lethal disease caused by a parasitic infection. However, some people carry the malaria parasite without ever showing signs of the disease. Thi...
MAY 31, 2018
Technology
MAY 31, 2018
PUREGRIP: Safe, User-Friendly Bottles for Biomedical Research
Foxx Life Sciences and Borosil Glass Works Joined up to Create a Lab Bottle Breakthrough...
JUL 01, 2018
Videos
JUL 01, 2018
Growing Patient Cells on a Chip for Personalized Drug Screens
This work could help eliminate animal models, and tailor medicine to the patient....
SEP 21, 2018
Clinical & Molecular DX
SEP 21, 2018
We will teach you to be a doctor, said us to the machine.
Clinical diagnosis are now possible in the hands of computers through machine learning. Whence, the reports of successful trials for the diagnostics....
Loading Comments...